Eikon Therapeutics Inc.

02/06/2026 | Press release | Distributed by Public on 02/06/2026 18:38

Statement of Changes in Beneficial Ownership (Form 4)

FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden hours per response... 0.5
(Print or Type Responses)
1. Name and Address of Reporting Person *
Foresite Capital Management IV, LLC
2. Issuer Name and Ticker or Trading Symbol
Eikon Therapeutics, Inc. [EIKN]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle)
C/O FORESITE CAPITAL MANAGEMENT, 9200 SUNSET BOULEVARD, SUITE 515
3. Date of Earliest Transaction (Month/Day/Year)
02/04/2026
(Street)
WEST HOLLYWOOD, CA 90069
4. If Amendment, Date Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/04/2026 C(1) 1,340,878 A $ 0 1,340,878 I See Footnote(2)
Common Stock 02/04/2026 C(1) 335,521 A $ 0 1,676,399 I See Footnote(2)
Common Stock 02/04/2026 C(1) 37,855 A $ 0 1,714,254 I See Footnote(2)
Common Stock 02/04/2026 C(1) 229,428 A $ 0 1,943,682 I See Footnote(2)
Common Stock 02/04/2026 C(1) 697,885 A $ 0 697,885 I See Footnote(3)
Common Stock 02/04/2026 C(1) 37,855 A $ 0 735,740 I See Footnote(3)
Common Stock 02/04/2026 C(1) 1,626 A $ 0 737,366 I See Footnote(3)
Common Stock 02/04/2026 C(1) 67,207 A $ 0 804,573 I See Footnote(3)
Common Stock 02/04/2026 C(1) 458,855 A $ 0 1,263,428 I See Footnote(3)
Common Stock 02/04/2026 C(1) 348,942 A $ 0 348,942 I See Footnote(4)
Common Stock 02/04/2026 C(1) 37,855 A $ 0 386,797 I See Footnote(4)
Common Stock 02/04/2026 C(1) 922 A $ 0 387,719 I See Footnote(4)
Common Stock 02/04/2026 C(1) 38,133 A $ 0 425,852 I See Footnote(4)
Common Stock 02/04/2026 C(1) 408,725 A $ 0 408,725 I See Footnote(5)
Common Stock 02/04/2026 P 55,555 A $18 1,318,983 I See Footnote(3)
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Series A Preferred Stock (1) 02/04/2026 C(1) 10,000,000 (1) (1) Common Stock 1,340,878 $ 0 0 I See Footnote(2)
Series A-1 Preferred Stock (1) 02/04/2026 C(1) 2,502,252 (1) (1) Common Stock 335,521 $ 0 0 I See Footnote(2)
Series A-1 Preferred Stock (1) 02/04/2026 C(1) 5,204,684 (1) (1) Common Stock 697,885 $ 0 0 I See Footnote(3)
Series A-1 Preferred Stock (1) 02/04/2026 C(1) 2,602,342 (1) (1) Common Stock 348,942 $ 0 0 I See Footnote(4)
Series B-1 Preferred Stock (1) 02/04/2026 C(1) 282,317 (1) (1) Common Stock 37,855 $ 0 0 I See Footnote(2)
Series B-1 Preferred Stock (1) 02/04/2026 C(1) 282,317 (1) (1) Common Stock 37,855 $ 0 0 I See Footnote(3)
Series B-1 Preferred Stock (1) 02/04/2026 C(1) 282,317 (1) (1) Common Stock 37,855 $ 0 0 I See Footnote(4)
Series B-1 Preferred Stock (1) 02/04/2026 C(1) 3,048,192 (1) (1) Common Stock 408,725 $ 0 0 I See Footnote(5)
Series C Preferred Stock (1) 02/04/2026 C(1) 12,123 (1) (1) Common Stock 1,626 $ 0 0 I See Footnote(3)
Series C Preferred Stock (1) 02/04/2026 C(1) 6,878 (1) (1) Common Stock 922 $ 0 0 I See Footnote(4)
Series C-1 Preferred Stock (1) 02/04/2026 C(1) 501,219 (1) (1) Common Stock 67,207 $ 0 0 I See Footnote(3)
Series C-1 Preferred Stock (1) 02/04/2026 C(1) 284,392 (1) (1) Common Stock 38,133 $ 0 0 I See Footnote(4)
Series D Preferred Stock (1) 02/04/2026 C(1) 1,711,025 (1) (1) Common Stock 229,428 $ 0 0 I See Footnote(2)
Series D Preferred Stock (1) 02/04/2026 C(1) 3,422,051 (1) (1) Common Stock 458,855 $ 0 0 I See Footnote(3)
Warrants $43.59 02/14/2025 02/14/2030 Common Stock 17,092 17,092 I See Footnote(2)
Warrants $43.59 02/14/2025 02/14/2030 Common Stock 34,185 34,185 I See Footnote(3)

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Foresite Capital Management IV, LLC
C/O FORESITE CAPITAL MANAGEMENT
9200 SUNSET BOULEVARD, SUITE 515
WEST HOLLYWOOD, CA 90069
X
Foresite Capital Fund IV, L.P.
C/O FORESITE CAPITAL MANAGEMENT
9200 SUNSET BOULEVARD, SUITE 515
WEST HOLLYWOOD, CA 90069
X
Foresite Capital Management V, LLC
C/O FORESITE CAPITAL MANAGEMENT
9200 SUNSET BOULEVARD, SUITE 515
WEST HOLLYWOOD, CA 90069
X
Foresite Capital Fund V, L.P.
C/O FORESITE CAPITAL MANAGEMENT
9200 SUNSET BOULEVARD, SUITE 515
WEST HOLLYWOOD, CA 90069
X
Foresite Capital Opportunity Management V, LLC
C/O FORESITE CAPITAL MANAGEMENT
9200 SUNSET BOULEVARD, SUITE 515
WEST HOLLYWOOD, CA 90069
X
Foresite Capital Opportunity Fund V, L.P.
C/O FORESITE CAPITAL MANAGEMENT
9200 SUNSET BOULEVARD, SUITE 515
WEST HOLLYWOOD, CA 90069
X
Foresite Capital VI-A Management, LLC
C/O FORESITE CAPITAL MANAGEMENT
9200 SUNSET BOULEVARD, SUITE 515
WEST HOLLYWOOD, CA 90069
X
Foresite Capital VI-A, LLC
C/O FORESITE CAPITAL MANAGEMENT
9200 SUNSET BOULEVARD, SUITE 515
WEST HOLLYWOOD, CA 90069
X

Signatures

FORESITE CAPITAL MANAGEMENT IV, LLC, By: /s/ James B. Tananbaum, Managing Member 02/06/2026
**Signature of Reporting Person Date
FORESITE CAPITAL FUND IV, L.P., By: Foresite Capital Management IV, LLC, Its: General Partner, By: /s/ James B. Tananbaum, Managing Member 02/06/2026
**Signature of Reporting Person Date
FORESITE CAPITAL MANAGEMENT V, LLC, By: /s/ James B. Tananbaum, Managing Member 02/06/2026
**Signature of Reporting Person Date
FORESITE CAPITAL FUND V, L.P., By: Foresite Capital Management V, LLC, Its: General Partner, By: /s/ James B. Tananbaum, Managing Member 02/06/2026
**Signature of Reporting Person Date
FORESITE CAPITAL OPPORTUNITY MANAGEMENT V, LLC, By: /s/ James B. Tananbaum, Managing Member 02/06/2026
**Signature of Reporting Person Date
FORESITE CAPITAL OPPORTUNITY FUND V, L.P., By: Foresite Capital Opportunity Management V, LLC, Its: General Partner, By: /s/ James B. Tananbaum, Managing Member 02/06/2026
**Signature of Reporting Person Date
FORESITE CAPITAL VI-A MANAGEMENT, LLC, By: /s/ James B. Tananbaum, Managing Member 02/06/2026
**Signature of Reporting Person Date
FORESITE CAPITAL VI-A, LLC, By: Foresite Capital VI-A Management, LLC, Its: Managing Member, By: /s/ James B. Tananbaum, Managing Member 02/06/2026
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date.
(2) The shares are held of record by Foresite Capital Fund IV, L.P. ("Fund IV"). Foresite Capital Management IV, LLC ("FCM IV") is the general partner of Fund IV and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum ("Tananbaum"), the managing member of FCM IV, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a "group", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and, other than Fund IV, disclaims beneficial ownership of the shares held by Fund IV, except to the extent of such person's pecuniary interest in such securities.
(3) The shares are held of record by Foresite Capital Fund V, L.P. ("Fund V"). Foresite Capital Management V, LLC ("FCM V") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum ("Tananbaum"), the managing member of FCM V, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a "group", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and, other than Fund V, disclaims beneficial ownership of the shares held by Fund V, except to the extent of such person's pecuniary interest in such securities.
(4) The shares are held of record by Foresite Capital Opportunity Fund V, L.P. ("Opportunity Fund V"). Foresite Capital Opportunity Management V, LLC ("FCOM V") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FCOM V, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a "group", as defined in Rule 13d-5 of the Exchange Act, and, other than Opportunity Fund V, disclaims beneficial ownership of the shares held by Opportunity Fund V, except to the extent of such person's pecuniary interest in such securities.
(5) The shares are held of record by Foresite Capital VI-A, LLC ("Fund VI-A"). Foresite Capital VI-A Management, LLC ("FC VI-A Management") is the general partner of Fund VI-A and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FC VI-A Management, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a "group", as defined in Rule 13d-5 of the Exchange Act, and, other than Fund VI-A, disclaims beneficial ownership of the shares held by Fund VI-A, except to the extent of such person's pecuniary interest in such securities.
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
Eikon Therapeutics Inc. published this content on February 06, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on February 07, 2026 at 00:38 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]